Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., is engaged in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, benefiting from the pet economy and the depreciation of the RMB [2][3]. Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. was established on November 15, 1982, and went public on January 22, 2025. It is a national key high-tech enterprise focusing on medical imaging and industrial non-destructive testing equipment [7]. - The company's main business revenue composition includes: medical ultrasound 71.16%, industrial ultrasound 17.30%, accessories 5.72%, X-ray 4.56%, and others 1.26% [7]. Financial Performance - For the first half of 2025, the company achieved operating revenue of 184 million yuan, a year-on-year increase of 15.00%, and a net profit attributable to shareholders of 68.45 million yuan, up 18.50% year-on-year [8]. - As of June 30, 2025, the company's overseas revenue accounted for 55.26%, benefiting from the depreciation of the RMB [3]. Market Activity - On October 28, the company's stock rose by 0.76%, with a trading volume of 57.19 million yuan and a turnover rate of 3.90%, bringing the total market capitalization to 10.755 billion yuan [1]. - The stock has seen a net outflow of 1.2384 million yuan from major funds today, with a continuous reduction in major fund positions over the past three days [4][5]. Product and Innovation - The company showcased its innovative veterinary medical imaging achievements at the 97th WVC annual meeting, focusing on pets, horses, and livestock, and engaged with industry experts on animal healthcare development [2]. - The company has developed a "Hongyun" system for portable ultrasound and DR devices that utilizes 5G networks for remote image transmission and interaction, enhancing the development of portable devices [2].
超研股份涨0.76%，成交额5718.71万元，今日主力净流入-123.84万